2016
$152M
from 19 investors over 19 rounds
Artios raised $152M on July 27, 2021
Investors: Schroders Capital, Omega Funds, Tetragon Financial Group Limited, Piper Sandler, Soleus Capital Management, L.P., Sofinnova Partners, RTW Investments, LP and SV Life Sciences
Artios raised $30M on December 3, 2020
Investors: Merck Group
Artios raised $83M on August 10, 2018
Investors: Arix Bioscience plc, IP Group plc, EQT Life Sciences, Andera Partners and SV Life Sciences
Artios raised $33M on September 21, 2016
Investors: Imperial College London, SV Life Sciences, M Ventures and Arix Bioscience plc
Artios raised undisclosed on September 6, 2016
Investors: SV Life Sciences